HRAS and thyroid gland carcinoma: Our WES analysis of the DNA extracted from the malignant thyroid tissue of patient III8 identified somatic heterozygote missense candidate variations in two genes: XRCC1 and HRAS, reported to have a role in thyroid cancer [38,57].